Yogurt and Cancer: The Truth Revealed

A variety of fresh foods including fruits, vegetables, and oils arranged on a table

Your morning yogurt may be doing something far more important than satisfying hunger — and the science behind it is more complicated, and more honest, than the headlines let on.

At a Glance

A 2022 meta-analysis of 476,160 participants found yogurt eaters had a statistically significant 7% lower risk of dying from any cause compared to low consumers.
The same analysis found no significant link between yogurt intake and cancer mortality — directly contradicting the most popular headline framing.
A separate line of research suggests yogurt eaten twice weekly may reduce risk of a specific type of colon cancer linked to gut bacteria.
The protective effect appears to plateau at roughly half a serving per day, meaning more yogurt does not mean more benefit.

What the Research Actually Shows About Yogurt and Mortality

A 2022 systematic review and meta-analysis published in the British Journal of Nutrition pooled 12 cohort studies covering 476,160 participants and 75,791 deaths. Researchers found that higher yogurt intake was associated with a pooled relative risk of 0.93 for all-cause mortality — a 7% reduction — and 0.89 for cardiovascular disease mortality. ^[1] Those numbers are modest but statistically significant, and they held up in dose-response analysis: each additional daily serving was independently associated with lower mortality risk from both causes. ^[1]

A 2019 meta-analysis reached a similar conclusion, finding that yogurt intake of 200 grams per day was inversely associated with all-cause mortality and cardiovascular mortality in dose-response analysis. ^[3] A more recent 2025 large-scale prospective study added that both full-fat and low-fat yogurt consumption correlated with reduced all-cause mortality risk. ^[5] The consistency across independent pooled analyses is notable, even if the effect sizes remain close to the margins of statistical confidence.

The Cancer Claim Is Where the Story Gets Complicated

The headline that yogurt lowers cancer risk deserves real scrutiny. The 2022 British Journal of Nutrition meta-analysis explicitly concluded there was no significant association between yogurt consumption and cancer mortality. ^[1] The 2025 prospective study echoed that finding, reporting no significant associations between yogurt consumption and cancer-specific mortality risk. ^[5] So when media coverage frames yogurt as a cancer-fighting food, the principal pooled evidence does not support that specific claim.

There is one important exception worth watching. Researchers from Harvard T.H. Chan School of Public Health and Mass General Brigham found that eating yogurt at least twice weekly was associated with lower rates of a specific subtype of colon cancer — tumors that test positive for Bifidobacterium bacteria in the proximal colon. ^[8] ^[9] That is a narrow but biologically plausible finding. The gut microbiome connection gives researchers a mechanism to investigate, which is more than most observational nutrition studies can offer. It does not, however, translate into a broad cancer-prevention claim.

Why Nutrition Science Keeps Producing Headlines That Disappoint

The yogurt story follows a pattern that repeats across nutrition research: a plausible food, a modest association in cohort data, a meta-analysis that pools the signal, and then media coverage that converts correlation into prescription. The structural problem is that long-term randomized controlled trials on diet and mortality are nearly impossible to conduct, so the field depends on observational cohorts where yogurt eaters may simply be healthier people in dozens of unmeasured ways. ^[2] The 2022 meta-analysis itself reported heterogeneity of 47.3% across studies for all-cause mortality, meaning results varied considerably between populations. ^[1]

The honest read on the evidence is this: regularly eating yogurt is associated with modestly lower mortality risk, particularly cardiovascular mortality, across multiple large independent analyses. That association plateaus around half a serving per day, so there is no case for eating more to live longer. ^[1] The cancer-mortality signal, despite what many headlines suggest, is largely absent from the main pooled evidence. What does exist is a specific and intriguing colon cancer subtype finding that deserves more rigorous follow-up. For a 40-year-old making breakfast choices, the yogurt habit looks reasonable. Calling it cancer prevention, however, is a stretch the data simply does not yet support.